Loss of FFAR2 has been shown to promote colon cancer and leukemia in murine models [39–41], and expression levels are relatively diminished among TCGA melanoma tissues vs. several other cancers according to the Human Protein Atlas [42]. This evidence concerns the gene FFAR2 and colonic neoplasm.